previously several years, the united kingdom has witnessed a revolution in medical bodyweight‑loss treatment plans — with the introduction of semaglutide (Wegovy®) into the rising level of popularity of tirzepatide (Mounjaro®). Now, Yet another identify is drawing awareness in both equally clinic